BNP PARIBAS ARBITRAGE/CALL/DIASORIN/110/0.1/19.12.24 | Market Closed - Borsa Italiana 03:46:46 2024-06-10 pm EDT | ||
| 0.561 EUR | -9.52% |
|
| Current month | -3.95% | ||
| 1 month | -5.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
DIASORIN S.P.A.
Latest news about DIASORIN S.P.A.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-10 | 0.561 | -9.52% |
| 24-06-07 | 0.62 | +3.68% |
| 24-06-06 | 0.598 | -1.64% |
| 24-06-05 | 0.608 | +3.23% |
| 24-06-04 | 0.589 | +3.51% |
Real-time Borsa Italiana
Last update June 10, 2024 at 03:46 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | DIASORIN S.P.A. |
| Issuer | 
BNP Paribas
|
| P206I1 | |
| ISIN | NLBNPIT206I1 |
| Date issued | 2024-03-01 |
| Strike | 110 € |
| Maturity | 2024-12-19 (192 Days) |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.785 € |
|---|---|
| Lowest since issue | 0.1795 € |
| Spread | 0.15 € |
| Spread % | 23.51% |
Company Profile
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Sector
-
Consensus: DiaSorin S.p.A.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
101.6
EUR
Average target price
101.7
EUR
Spread / Average Target
+0.11%
- Stock Market
- Warrants
- P206I1 Warrant
